PECS I Block for Breast Subpectoral Implant Surgery

University Hospital, Lille56 enrolled

Overview

Breast augmentation surgery can cause important postoperative pain, especially when bilateral subpectoral implants are used. The investigators hypothesized that a technique of regional analgesia, the pectoral nerve block type I (or "PECS I block") would reduce pain within the first twenty-four hours and, in turn, morphine consumption and associated side effects. This is a randomized, controlled, double-blind study which compares intra and postoperative analgesia with or without PECS I block in breast surgery.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

Conditions

Pain, Postoperative

Interventions

Ropivacaine (PECS bloc)DRUG

Ropivacaine 3.75mg/mL Injection of a local anesthetic between pectoral major and pectoral minor muscles

PlaceboDRUG

20 mL saline 0.9%

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Every female who will benefit of a bilateral subpectoral breast augmentation * Age more than 18 years * Social insured Exclusion Criteria: * refusal of the patient * Age less than 18 years * Inability to consent * History of thoracic surgery or breast implants * Pregnancy * Inability to use a patient controlled analgesia * Contraindication of the use of opioids or local anesthetics * Pathology of hemostasis, infection * Can not use a PCA * Patients under long-term opioids (WHO pain ladder 2 and 3) * Patient presenting neuropathic pain during the preoperative period (score greater than or equal to 4 to the DN4 questionnaire, or taking anti-epileptic or antidepressant treatments for neuropathic pain)

Locations (1)

Hôpital Roger Salengro, CHU de Lille

Lille, France

Outcomes

Primary Outcomes

Morphine consumption

Morphine consumption by use of patient control analgesia within the first twenty-four hours after surgery.